Literature DB >> 7379006

Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx.

J M Bedwinek, C A Perez, D J Keys.   

Abstract

From 1955 to 1976, 111 patients were treated with definitive radiotherapy for epidermoid carcinoma of the nasopharynx. There was a definite correlation between recurrence at the primary site and T-stage; 9.5% of T1-2 patients, 38.1% of T3 patients and 54.1% of T4 patients had local recurrences. Similarly, failure in the neck correlated with N-stage, being negligible for N0 and N1 but 28.6% for N2 and 36.1% for N3. The incidence of distant metastases had no correlation with T-stage but correlated very closely with N-stage. The patients were grouped into four T and N categories, T1-2 N0-1, T1-2 N2-3, T3-4 N0-1, and T3-4 2-3. The five year relapse-free survival for the T1-2 N0-1 category was 69% but was only about 20% for each of the other three categories. The major cause of poor survival for the T3-4 N0-1 category was recurrence at the primary site, whereas for the T1-2 N2-3 and T3-4 N2-3 categories, it was the high incidence of distant metastases, approximately 50%. Recommendations are to increase dose at the primary site for T3-4 N0-1 patients and to institute clinical trials testing adjuvant chemotherapy for patients with neck stages N2 and N3.

Entities:  

Mesh:

Year:  1980        PMID: 7379006     DOI: 10.1002/1097-0142(19800601)45:11<2725::aid-cncr2820451105>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Ifosfamide-based chemotherapy in locoregionally advanced nasopharyngeal cancer: evaluation of its role as neoadjuvant chemotherapy.

Authors:  Sarbani Ghosh-Laskar; Jai Prakash Agarwal; Pranshu Mohindra; Manju Sengar; Shilpa Vyas; V R Pai; Ashwini Budrukkar; Prathamesh Pai; Anil K D'Cruz; Ketayun Ardeshir Dinshaw
Journal:  Med Oncol       Date:  2008-12-02       Impact factor: 3.064

2.  Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation.

Authors:  L B Harrison; D G Pfister; D Kraus; J G Armstrong; M J Zelefsky; J Wiseberg; G J Bosl; E W Strong; J P Shah
Journal:  Skull Base Surg       Date:  1994

3.  MR analysis of nasopharyngeal carcinoma: correlation of the pattern of tumor extent at the primary site with the distribution of metastasized cervical lymph nodes. Preliminary results.

Authors:  M Wakisaka; H Mori; N Fuwa; A Matsumoto
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

4.  Carcinoma of the nasopharynx--comparison of the UICC and Ho clinical staging systems.

Authors:  S L Roth; G Bertram; H Sack
Journal:  Klin Wochenschr       Date:  1989-01-20

5.  Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.

Authors:  Shaojun Lin; Jiade Jay Lu; Lu Han; Qisong Chen; Jianji Pan
Journal:  BMC Cancer       Date:  2010-02-10       Impact factor: 4.430

Review 6.  Cancer of the nasopharynx: functional surgical salvage.

Authors:  William Ignace Wei
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

7.  Outcome of surgical management of persistent or recurrent neck mass in patients with nasopharyngeal carcinoma after radiotherapy.

Authors:  Cheng-Yu Lin; Sen-Tien Tsai; Ying-Tai Jin; Ming-Wei Yang; I-Chun Yeh; Jenn-Ren Hsiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-07       Impact factor: 2.503

8.  Radiation-induced bilateral optic neuropathy in cancer of the nasopharynx. Case failure analysis and a review of the literature.

Authors:  O B Wijers; P C Levendag; G P Luyten; B A Bakker; N J Freling; J Klesman-Bradley; E Woudstra
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

9.  Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.

Authors:  Ling Zhang; Yong-xue Zhu; Yu Wang; Cai-ping Huang; Yi Wu; Qing-hai Ji
Journal:  Ann Surg Oncol       Date:  2010-08-25       Impact factor: 5.344

10.  WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma.

Authors:  Chawalit Ngernsombat; Pongphol Prattapong; Noppadol Larbcharoensub; Krittika Khotthong; Tavan Janvilisri
Journal:  Curr Oncol       Date:  2021-07-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.